70 participants
Efficacy and Safety of Sintilimab With or Without Radiotherapy in Patients With Recurrent or IV NSCLC (EGFR -, ALK -) After Failure of Platinum-based Chemotherapy: A Randomized,Open Labled, Phase II Clinical Study
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-08-14
- Start Date:
- 2020-01-01
- Completion:
- 2022-08-01
Conditions
- Lung Neoplasms
Interventions
- DRUG
- RADIATION
No Results Yet